Page numbers printed in boldface type refer to tables or figures.
AAR (ask, advise, refer) model,96, 98
AARC Tobacco-Free Lifestyle Roundtable,96
Accidentsrates of for homeless,89
risk of injury in individuals with SMI,8–9
Achieving Healthy Lifestyles in Psychiatric Rehabilitation (ACHIEVE),179Adherence, to treatmenthealthy living skills and,168–169
shared decision making and,148
Advocacy, by health care professionals,92
African Americans.
See also Race
access to health care and,75
community-based participatory research and,30,
31,
33, 38–41
peer navigator programs and,230
prevalence of smoking and,241
trust of health information by,289
Age.
See also Age at onset; Children and adolescents; Older adults
prevalence of smoking by,240
smoking cessation and,244
Agency for Healthcare Research and Quality (AHRQ),67,
134Age at onset, of diabetes in individuals with SMI,113
Agranulocytosis,123
Alcohol use disorder,50, 95
Alzheimer’s disease,6, 11
Ambulatory care–sensitive conditions (ACSCs),67
Amenorrhea,7American Academy of Family Physicians,135
American Association of Clinical Endocrinologists,68
American Diabetes Association,68
American Indian/Alaska Natives, and prevalence of smoking,241
American Psychiatric Association (APA),56, 68, 245–246, 250, 256
Americans with Disabilities Act,41
Amisulpride,104
Amitriptyline,271Antidepressants.
See also Selective serotonin reuptake inhibitors; Tricyclic antidepressants
diabetes and,114–115
hypertension and,113
myocardial infarction and,109
osteoporosis and,117
risk of falls and fractures,8
smoking cessation and,254
weight gain and,106, 107–108
Antipsychotics.
See also Clozapine; Olanzapine
bone mineral density and,5, 7–8
cancer and,120
cardiovascular disease and,9, 108, 109, 110, 111
diabetes mellitus and,113–115
diabetic ketoacidosis and,116
dyslipidemia and,107
hypertension and,113
metabolic syndrome and,104
osteoporosis and,116–117
pneumonia and,6, 12, 118–119
screening for metabolic syndrome and,68
sexual dysfunction and,13
smoking and smoking cessation,243, 254
Anxiety disorders, and heart disease,5Aripiprazole,104, 105, 110
Asenapine,271Asian Americans, and community-based participatory research,32, 35,
See also Race
Aspiration pneumonia,118–119
Assessment, and smoking cessation,247
Asthma,6, 11, 12
Autoimmune disease,7, 14–15
Bariatric surgery,277
Barriersto health and health care for people with SMI,16, 66–70, 166, 298
health navigators and systemic,232, 234
to mental health care in patient-centered medical homes,136
to physical activity for people with SMI,95
to smoking cessation,245
to weight loss,269, 278
Behavioral health care manager, and collaborative care model,56
Behavioral interventionsfor smoking cessation,250–253
for weight management,273–277
Beta-blockers,70
Bipolar disorderaccess to health care and,66–67
asthma and,6, 12
chronic kidney disease and,7, 13
diabetes and,113
metabolic syndrome and,104
pneumonia and,118
smoking and,240, 241, 243
Blood-borne viruses.
See also HIV; Infectious diseases
medical screening tests for,69
SMI as risk factor for contracting,50
Blood pressure, monitoring of,124.
See also Hypertension
Bone fracture, and antipsychotics,116, 117
Bone mineral density (BMD),5, 7–8, 116, 117
Boston University Center of Psychiatric Rehabilitation,17
Bridge modelpeer-led health navigation for psychiatric disability and,229–230
programs for healthy living skills and,190,
198–
200, 210
Buprenorphine,54
Bupropion,253, 254, 256
Canadian Task Force on Preventive Health Care,248
Cancer,68–69, 119–121, 224–225, 243
Cannabis,49
Carbamazepine,118
Cardiomyopathy,112–113
Cardiovascular diseasepoverty and,87
psychotropic medications and,108–113
quality of care and,69
screening for risk factors in persons with SMI,68
smoking and,243
Cardiovascular system, and morbidities in people with SMI,5, 9–10
Care management, and patient-centered medical homes,136–137
Cariprazine,271Case examplesof access to health care,75–77
of antipsychotic-related diabetes,115
of cardiovascular disease and psychotropic medications,110–111, 112–113
of co-occurring SMI, substance use disorder, and physical illness,50–51, 57–58, 59–60
of health navigators,221–222
of healthy living skills,212–213
of implementation of community-based participatory research,38–41
of kidney disease and psychotropic medications,122–123
of obesity and weight management,279–280
of patient-centered medical homes,138
of physical illness comorbid with SMI,15
of shared decision making,156–157
of smoking cessation,257–258
of weight gain from psychotropic medications,106–107
Celiac disease,12–13
Centers for Disease Control and Prevention (CDC),16, 287, 290
Children and adolescents, and antipsychoticsbone formation in,117
cardiovascular damage in,108
diabetes in,114–115
risk of weight gain in,105
Chlorpromazine,271Chronic care model, patient-centered medical home as extension of,134
Chronic Disease Self-Management Program (CDSMP),190,
204Chronic kidney disease (CKD),7, 13–14, 121–123
Chronic obstructive pulmonary disease (COPD),6, 11
Civil rights, and COVID-19 pandemic,290
Clinical Practice Research Datalink Registry,13
Clinician’s Guide to Treating Tobacco Dependence (AARC Tobacco-Free Lifestyle Roundtable 2014),96
Clozapine.
See also Antipsychotics
diabetes mellitus and,114
diabetic ketoacidosis and,116
dyslipidemia and,107
metabolic syndrome and,104
myocarditis and,112
neutropenia and,123
pneumonia and,12, 118
skin neoplasms and,5, 7
sudden cardiac death and,111
weight gain and,106, 270,
271Cognitive-behavioral therapyBridge program and,229
healthy living skills and,170
Cognitive deficitshealth care and,166
smoking cessation and,245, 247
Collaborationcommunity-based participatory research and,27
shared decision making and,148
Collaborative care modelfor co-occurring SMI, substance use, and physical illness,56
healthy living skills and,197patient-centered medical home model and,135
Communicationhealth care utilization and,222,
223–
224healthy living skills and,169
integrated care models and,58
Community, concept of in community-based participatory research,26
Community-based participatory research (CBPR)case study of implementation,38–41
critical assessment of,36–38
description of,24–25
future of,41–43, 300
principles of,25–28
summary of literature on,28–36
Community Health Scholars Program,24
Community health workers (CHWs),225–226,
227Community partnered participatory research (CPPR),25
Comorbidity, of mental disorders.
See also Physical illness
prevalence of in individuals with SMI,3
smoking and,240
Compliance, and shared decision making,147,
148Computers.
See Internet
Context, of community-based participatory research,27
Coordination, and health care utilization,222,
223, 224
Coping skills, and healthy living skills,168
Coronary heart disease,5, 9, 108–109
Costs, of co-occurring substance use, SMI, and medical disorders,53–54.
See also Funding
Counseling, for smoking cessation,250
COVID-19health care decisions related to,287–290
health literacy and,290–291
implications for mental health care providers,291–293
as new normal,293
stress, isolation, and exacerbation of mental disorders,286–287
Criminal justice systemaccess to health care and,74
health challenges of people living with SMI and,298
life choices of individuals with SMI and,85–
87, 90
Culturedefinition of “significant life goal” and,2
health navigators and,225, 234
shared decision making and,151
Danish National Patient Registry, and Danish Psychiatric Registry,14
Death, from respiratory disease in individuals with SMI,118.
See also Mortality
Decision making.
See Shared decision making
Decision support tools, for shared decision making,155–157
Deinstitutionalization, and homelessness,89
Deliberation, as stage of shared decision making,150–151
Dental health.
See Tooth decay
Depression.
See also Major depressive disorder
asthma and,12
domestic violence and,88
heart disease and,5, 9
homeless population and,89
obesity and,268
as risk factor for diabetes,114
smoking and,240, 243
Depression and Bipolar Support Alliance,292
Diabetes Awareness and Rehabilitation Training (DART),185Diabetes Management Program,209Diabetes mellitus (DM),4,
5, 7, 113–115, 124
Diabetes Prevention Program Group Lifestyle Balance intervention plus mobile health (mHealth),173Diabetic ketoacidosis,115–116
Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association 2013),246
Diathesis-stress model, of co-occurring SMI, substance use disorder, and physical illness,51–53
Dietbehavioral weight management and,274
health literacy and,269
lifestyle choices of individuals with SMI and,85, 94, 170
Digestive system, and morbidities in people with SMI,6, 12–13
Disability, definition of by Social Security Administration,2
Domestic violencecommunity-based participatory research and,28,
29,
34, 35
people with SMI as victims of,88
Downward drift, and socioeconomic status of people with schizophrenia,298
Dyslipidemia,107–108
Eating disorders,94
E-cigarettes,255
Ecological perspective, and community-based participatory research,26
Economics.
See Costs; Funding; Poverty; Socioeconomic status
Edentulousness,5, 8
EducationBridge program and,229
for health navigators,227,
232, 233
healthy living skills and,167
of patients about psychotropic medications,92
poverty of individuals with SMI and,84
prevalence of smoking and level of,240–241
on shared decision making for health care professionals,154–155
tobacco treatment training for psychiatry residents,256
Electrocardiogram (ECG), baseline,124
Emergency departments (EDs), use of by persons with SMI,67.
See also Hospitals
Empowermentfuture of care for people with SMI,299–300
shared decision making and,147
Endocrine system diseasescomorbidities in people with SMI and,7, 14
psychotropic medications and,113–116
Engagement, and shared decision making,148
Enhancing QUality of Care in Psychosis (EQUIP) project,273
Epidemics, history of,286, 293.
See also COVID-19
Epidemiology.
See Prevalence
Epilepsy,5, 10
Estrogen, and psychotropic medications,8, 13, 120–121
Ethnicity.
See Race
Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES),254
Exercisebehavioral weight management and,274, 277
lifestyle choices of individuals with SMI and,86, 94–95, 170
Extrinsic motivation,168
Falls, risk of fractures and,8
Family history, of early cardiac death,124
5 A’s and 5 R’s models, for smoking cessation and weight management,96, 98, 248–250
Food and Drug Administration,291
Fearavoidance of health care and,165, 166
extrinsic motivation for healthy living skills and,168
Finger prick tests,124
Focus groups, and community-based participatory research,39–40
Funding, of peer health navigation,231,
232.
See also Costs
Gender, and community-based participatory research,28,
30.
See also Women
GLOBOCAN 2018,119
Haloperidol,111
Harm reduction, and alternatives to cigarettes,255
Health.
See also Health care; Obesity; Physical illness
challenges for people living with SMI,298
COVID-19 pandemic and literacy on,290–291
ethnic disparities in trust of information on,289–290
motivation as key factor in maintaining,165
Health belief model, and healthy living skills,165
Health care.
See also Barriers; Community-based participatory research; COVID-19; Emergency departments; Health; Health care professionals; Health navigators; Hospitals; Integrated care; Nursing homes; Patient-centered medical home; Shared decision making
challenges to utilization of and wellness,222,
223–
224costs of co-occurring substance use, SMI, and medical disorders,53–54
factors contributing to disparities in,70–77
fear and avoidance of,165, 166
life choices of individuals with SMI and,85–
86, 90–91
medical screening tests for individuals with SMI,68–69
prisons and,90
psychological side effects of,52
standard of care and quality treatments,69–70
systemic issues in,222, 234
traditional medical care models of,132
weight stigma and,270–271
Health care professionalslifestyle choices and recommendations for,96–98
recommendations for treatment of people with SMI,91–92
smoking cessation and,242
training in shared decision making for,154–155
Health navigatorscase example of,221–222
challenges for,231–234
community health workers and,226,
227description of model,224–225
for psychiatric disability,226–230
Health and Recovery Peer Program (HARP),194,
195Healthy living skills.
See also Lifestyle choices
creation and maintenance of,164–167
definition of,164
future of programs for,213–214
health in general population compared to individuals with SMI,169–171
research on,190,
191–
209, 210–213
specific programs for,171–172,
173–
188, 189
targets for intervention,167–169
Heart disease,87.
See also Cardiovascular disease
Heart rate variability,10
Helping Older People Experience Success (HOPES),190,
192,
206, 210
Hematological diseases, and psychotropic medications,123
Hepatitis C,50, 69, 95
Heroin use disorder,49
Hip fracture, and antidepressants,8
HIVas epidemic or pandemic,286
prevalence of in individuals with SMI,50, 96
screening tests for,69
substance use and,95
Homelessnessaccess to health care and,67, 74, 75
community-based participatory research and,30,
31, 38–41
health challenges of people living with SMI and,298
life choices of individuals with SMI and,85, 88–89
Homicide, people with SMI as victims of,85, 88
Hospitals, smoking by patients in psychiatric,242, 256–257.
See also Emergency departments; Health care
Housing, and co-occurrence of SMI and substance use disorders,53.
See also Homelessness
Hyperglycemia,124
Hyperprolactinemia,13
Hypertension, and psychotropic medications,113.
See also Blood pressure
Hypoalgesia,6, 11
Hypogonadism,8
Hypothyroid disorder,7, 123
Iloperidone,271Imipramine,271Immigrants and refugees, and community-based participatory research,28,
34, 35
Immune systemcombined impact of mental illness and substance use on,52
morbidities in people with SMI and,7, 14–15
Infectious diseases, and homelessness,89,
See also Blood-borne viruses; COVID-19; Skin infections
Influenza, and epidemics,286, 293
Information exchange, and shared decision making,150, 151
InSHAPE intervention,172,
174–
175,
188, 189, 190
Institute of Medicine,299
Insurance, and health care,66, 256
Integrated care.
See also Patient-centered medical home
access to health care and,71
co-occurrence of SMI with substance use and physical illness,55–58
peer health navigation and,231,
232Integrated Coaching for Better Mood and Weight intervention,274
Integrated Illness Management and Recovery (IIMR),191, 210
Integumentary system, and morbidities in people with SMI,4,
5, 7
Intensive primary care, and patient-centered medical homes,136
Interactive, multimedia approach, to shared decision making,154
Interferon-alfa,52
International Agency for Research on Cancer,119
International Classification of Diseases (ICD-10),246
International Group for The Study of Lithium Treated Patients,123
International Patient Decision Aids Standards (IPDAS),156
Internetbehavioral weight management and,275
COVID-19 pandemic and support groups,292
shared decision making and,154
smoking cessation and,253
Interpersonal relationships, and healthy living skills,169.
See also Family history; Social factors
Intrinsic motivation,167
In vivo supports, health navigators as,228–229
Irritable bowel syndrome (IBS),12–13
Iterative process, community-based participatory research as,27
Kidney disease, and psychotropic medications,121–123.
See also Chronic kidney disease
Kraepelin, Emil,2
Latinos.
See Race and ethnicity
access to health care and,75
community-based participatory research and,29,
33peer navigator programs and,230
Leukocytopenia,123
LGBT populationcommunity-based participatory research and,28,
33, 35
health challenges of people living with SMI,298
Life expectancy, of individuals with SMI,3–4, 65, 84, 87.
See also Mortality
Life Goals Collaborative Care (LGCC),190,
201,
203Lifestyle Balance program,180Lifestyle choices.
See also Healthy living skills
chronic medical conditions in individuals with SMI,52
consequences of in individuals with SMI,85–
87, 92–98
multiple poor habits in individuals with SMI,169, 170
osteoporosis and,116
recommendations for health care professionals,96–98
Lithium.
See also Mood stabilizers
chronic kidney disease and,14, 121–123
hypothyroidism and,123
reduced fracture risk and,117
skin conditions and,7
weight gain and,271Lived experience leaders, and community-based participatory research,42–43
Living Well intervention,190,
196,
205, 210
Major depressive disorder (MDD).
See Depression
access to health care and,66–67
metabolic syndrome and,104
smoking cessation and,244, 248
Manualized curriculum, for peer navigator program in community-based participatory research,40
Medicaid,54, 66, 67, 68, 70, 72, 256
Medical conditions.
See Physical illness
Medical screening tests,68–69
Medications.
See also Antidepressants; Antipsychotics; Mood stabilizers
cancer and,119–121
cardiovascular disease and,108–113
dyslipidemia and,107–108
healthy living skills and,168–169
hematological diseases and,123
kidney diseases and,121–123
metabolic syndrome and,103–104, 123–124
obesity and,104–107, 269–270, 272
psychiatrists and education of patients about,92
respiratory tract diseases and,118–119
risk of falls and fractures,8
sexual dysfunction and,13
smoking cessation and,253–254
weight gain and,94,
271Mental disorders, impact of COVID-9 on symptoms of,286–287.
See also Bipolar disorder; Depression; Personality disorders; Posttraumatic stress disorder; Psychotic disorders; Schizoaffective disorder; Schizophrenia; Serious mental illness
Mental health care.
See Psychiatrists
Metabolic syndromeas medical comorbidity in individuals with SMI,49–50
psychotropic medications and,103–104, 123–124
screening tests for,68
substance use disorder as risk factor for,50
Metformin,272
Middle East respiratory syndrome (MERS),286, 288
Migraines,6, 10–11
Mirtazapine,271MISSION (Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking),57
Monitoring, of weight gain in people with SMI,272–273
Monoamine oxidase inhibitors (MAOIs),109
Mood stabilizers.
See also Lithium
osteoporosis and,117
pneumonia and,118
weight gain and,106, 108
Morbidity.
See also Health; Physical illness
multimorbidity and,48
poverty and,87
smoking and,243
types of in individuals with SMI,4–15
Mortality.
See also Death; Life expectancy
co-occurring mental health disorders and substance abuse,47–48
homelessness and rates of,89
people released from prisons and rates of,90
rates of for individuals with SMI,3–4
smoking and,243
Motivationhealthy living skills and,167–168
as key factor in maintaining health,165–166
for smoking cessation,244
Motivational interviewing, and smoking cessation,250–251
MOVE intervention,172,
182, 278
MOVE+UP program,274
Myocardial infarction (MI),108, 109–110
Myocarditis,112–113
National Association of State Mental Health Program Directors,301
National Cancer Institute,248
National Committee for Quality Assurance (NCQA),133,
135National Council for Behavioral Health,301
National Health Interview Survey,67
National Institute of Allergy and Infectious Diseases,290, 293
National Institutes of Health,16
National Survey on Drug Use and Health,48, 240, 241
Nervous system, and morbidities in people with SMI,5–
6, 10–11
Neurodegenerative diseases,11
Neutropenia, clozapine-associated,123
Nicotine dependence, and nicotine withdrawal syndrome,241
Nicotine replacement therapy (NRT),245, 253–254, 256
North American Association for the Study of Obesity,68
Nurse care managers, and patient-centered medical homes,138
Nursing homesearly institutionalization of persons with SMI in,3
quality of and admission of persons with SMI to,70
Obesity.
See also Weight gain
cardiovascular disease and,108
causes of,268–271
eating patterns of people with SMI and,94
prevention and treatment of in people with SMI,271–280
psychotropic medications and,104–107
risk of in individuals with SMI,267–268
as risk factor for sleep apnea,10
Obstructive sleep apnea,5, 10
Olanzapinediabetes mellitus and,114
diabetic ketoacidosis and,116
dyslipidemia and,107
metabolic syndrome and,104
sudden cardiac death and,111
weight gain and,105, 106,
271Older patients.
See also Age
antidepressants and risk of falls and fractures,8
dosages of tricyclic antidepressants for,111
pneumonia in individuals with SMI,118
Opioid epidemic, and opioid use disorder,48–49
Osteoporosis,7–8, 116–117
Ottawa Hospital Research Institute,156
Pain, schizophrenia and altered perception of,6, 11
Paliperidone,271Parkinson’s disease,6, 11
Paroxetine,271Participatory action research (PAR),25, 28
Patient activation, and shared decision making,153–154
Patient-centered medical home (PCMH)augmentation of,136–138
challenges to implementation of,131–132, 135–136
description of,133–135
MISSION services and,57
Patient-Centered Outcomes Research Institute,24
Patient navigators,224–225
Patient Protection and Affordable Care Act (ACA),59, 66, 67, 71, 225, 301
Pay-for-performance (P4P),231
Peer coaching, and behavioral weight management,275
Peer navigator programs.
See also Health navigators
community-based participatory research and,40
models of for psychiatric disability,229–230
Peers for Progress model,225
Peer support specialists, and patient-centered medical homes,136
Personality disorders, and impact of stigma on access to health care,73
Person-centered care, and shared decision making,149
Physical illness.
See also Health; Health care; Morbidity
case example of in individual with SMI,15
case examples of substance use comorbid with SMI and physical illness,50–51, 57–58, 59–60
etiology of substance use comorbid with SMI and physical illness,51–53
impact of on wellness,16–17
life choices of individuals with SMI and,85–
87mental health care for substance use comorbid with SMI and physical illness,55–60
mortality, costs, and treatment of substance use comorbid with SMI and physical illness,53–55
mortality rates in individuals with SMI and,3–4
prevalence of substance use comorbid with SMI and physical illness,47–50
psychiatric providers and,15–16
types of in individuals with SMI,4–15
Physiology, and obesity,270
Picker Institute,146–147
Planned behavior, and maintenance of health,165
Pneumonia,6, 12, 118–119
Polypharmacy, and risk of chronic kidney disease,122
Posttraumatic stress disorder (PTSD)obesity and weight management,268, 274, 278, 279
smoking and,240
Povertyaccess to health care and,74, 75
co-occurrence of SMI and substance use disorders,53
health consequences of for individuals with SMI,84, 87, 93, 298
smoking and,240
PREMIER study,178President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982),146
Prevalenceof comorbidity in individuals with SMI,3
of co-occurring SMI, substance use disorder, and physical illness,48–51
of SMI in general population,1–2, 47
of smoking in individuals with SMI,49, 239–243
Prevention Quality Indicators (PQIs),67
Primary Care Access, Referral, and Evaluation (PCARE),137,
193, 210
Prisons, chronic medical conditions and health care in,90.
See also Criminal justice system
Provider-patient relationship, and shared decision making,148–149
Psychiatristsaccess to health care for patients with SMI,70
education of patients about medications,92
implications of COVID-19 for,291–293
integrated care for co-occurrence of SMI with substance use and physical illness,55–60
physical illness in patients with SMI and,15–16
smoking cessation and,242, 245–246, 249
stigmatizing attitudes toward individuals with SMI and substance use,55
Psychosocial interventions, for smoking cessation,250–253
Psychotic disorders.
See also Schizoaffective disorder; Schizophrenia
access to health care and,66–67
homeless population and,89
obesity and,268
sedentary behavior and,170
smoking and smoking cessation,243, 248
PubMed,171
QTc prolongation,110–111, 125
Quality of Life for Persons With Bipolar Disorder,181Quality treatments, and health care,69–70
Quetiapine,104, 111,
271Quitlines, and smoking cessation,252
Race, and ethnicity.
See also African Americans; Asian Americans; Latinos
disparities in trust of health information,289–290
as focus of CBPR studies,28, 35
health navigators and,225
prevalence of smoking and,241
social determinants of health and,74–75, 298
Recovering Energy Through Nutrition and Exercise for Weight Loss (RENEW),177Relapse, and smoking cessation,248
Reproductive system, and morbidities in people with SMI,6–
7, 11–12, 13
Research.
See also Community-based participatory research
on community health workers,226
future of,300
on health navigators for psychiatric disability,227–228, 229–230
on healthy living skills,171–172,
173–
188, 189, 190,
191–
209, 210–213
on homeless population,89
influence of tobacco industry on,242
on peer navigator programs,230
Resilience, and weight management,279
Resistance, and shared decision making,147,
148Respiratory diseases,6, 118–119, 243.
See also Pneumonia
Risperidone,105, 107, 111,
271Schizoaffective disorder,113, 244
Schizophreniaaltered pain perception and,6, 11
antipsychotics and risk of bone fracture,116
autoimmune disease and,14–15
cancer and,119, 120
cannabis use and,49
celiac disease and,12–13
chronic obstructive pulmonary disease and,6diabetes and,113
epilepsy and,5, 10
metabolic syndrome and,104
pneumonia and,118
response to pain and,166
sexual dysfunction and,6, 13
smoking and smoking cessation,94, 240, 241, 242, 243, 244
socioeconomic status of people with,298–299
stigma as factor in access to health care,73
sudden cardiac death and,5, 9, 111
Screening, for obesity in people with SMI,272–273
Sedentary behavior.
See Exercise
Selective serotonin reuptake inhibitors (SSRIs),110, 117, 121
Self-determinationfuture of care for people with SMI,299–300
motivation for improving health behaviors and,165
shared decision making and,147, 150
Self-efficacyhealthy living skills and,168
obesity and,268–269
Self-managementhealth care utilization and wellness,222,
223, 224
healthy living skills and,168
shared decision making and programs for,153–154
Self-Management Addressing Health Risk Trial (SMAHRT),202Self-medicationsmoking cessation and,245
substance use in individuals with SMI as,52
Self-monitoring, and healthy living skills,167
Serious mental illness (SMI).
See also Health care; Healthy living skills; Medications; Mental disorders; Morbidity; Mortality; Obesity; Physical illness; Research; Shared decision making; Substance use
concept of acting in person’s world,300–301
consequences of lifestyle choices,85–
87, 92–98
definition of,2
dimensions of wellness specific to,16–17
empowerment and self-determination as principles in care of,299–300
homelessness and,88–89
involvement with criminal justice system,90
mortality rates and,3–4
persistence and chronicity of,2
poverty and,84, 87, 93
prevalence of,1–2, 47
rate of HIV in,286
substandard medical care and,90–91
violent victimization and domestic violence,87–88
Serotonin-norepinephrine reuptake inhibitors (SNRIs),109, 113
Sertindole,271Severe acute respiratory syndrome (SARS),286, 288
Sexual behaviors, and life choices of individuals with SMI,87, 95–96
Sexual dysfunction,6, 13
Sexually transmitted diseases,96
Shared decision making (SDM)foundation and ethics of,146–150
health navigators and,228
history of concept,145–146
impact of,152–153
model of,150–152
tools and interventions to support,153–157
Simplified Intervention to Modify Physical Activity, Lifestyle and Eating (SIMPLE),187Skeletal system, diseases of,4,
5, 7–9, 116–117
Skin infections,4,
5Sleep disturbance, and weight gain,270,
See also Obstructive sleep apnea
Smartphone apps.
See Telephone
Smokingcessation of,243–258
effects of on morbidity and mortality,243
exercise and,95
life choices of individuals with SMI and,86, 93–94, 96
prevalence of in individuals with SMI,49, 239–243
Social determinants of health.
See also Housing; Poverty
access to health care and,74–77
co-occurrence of SMI and physical illness,52–53
effects of on people living with SMI,298–299
Social distancing, and COVID-19,290
Social factors, and smoking cessation,245,
See also Interpersonal relationships
Social media, and smoking cessation,253
Social Security Administration,2, 84
Social workers, and patient-centered medical homes,136
Socioeconomic status, and poverty in individuals with SMI,84, 87
Spanish flu epidemic (1918),286, 293
Specialty medical homes, and patient-centered medical homes,137–138
Special populations, healthy living skills programs for,210–211.
See also Children and adolescents; Older adults
Stages of change model, of smoking cessation,247–248
Stigmabarriers to health care for individuals with SMI and,166
lifestyle choices of people with SMI and,98–99
peer health navigation and,232, 233
provider-level factors in access to health care and,72–73
treatment of co-occurring SMI and substance use disorders,55
weight management and,270–271, 278
STRIDE intervention,172,
183,
184Structural interventions, for smoking cessation,255–258
Study of Lithium Treated Patients,121
Substance Abuse and Mental Health Services Administration (SAMHSA),255–256, 287, 290, 301
Substance use, and substance use disorders (SUDs).
See also Smoking
case examples of co-occurrence with SMI and physical illness,50–51, 57–58, 59–60
etiology of co-occurrence with SMI and physical illness,51–53
life choices of individuals with SMI and,87, 95
mortality, costs, and treatment implications of co-occurrence with SMI and physical illness,53–55
prevalence of co-occurrence with SMI and physical illness,47–50
psychiatric practice and co-occurrence of with SMI,55–60
Sudden cardiac death (SCD),5, 9, 111, 124, 125
Suicide, and homelessness,89
Supervision, and peer health navigation,232, 233
Support groups, COVID-19 pandemic and online,292
System-level factors, in access to health care,71–72
Targeted Training for Illness Management,190,
207–
208Technology, and behavioral weight management,274–277.
See also Internet; Telephones
Telephonesbehavioral weight management and,276–277
smoking cessation and,252–253
Thioridazine 110,111,
271Tobacco use, promotion of by industry,241–241.
See also Smoking
Tooth decay,5,
8Torsades de pointes (TdP),110
Training.
See Education
Transportation, and access to health care,224
“Treating Tobacco Use and Dependence” (U.S. Public Health Service 2008),248, 250, 251
Treatment.
See Adherence; Behavioral interventions; Cognitive-behavioral therapy; Medications; Psychiatrists
Tricyclic antidepressants (TCAs)coronary heart disease and,109
hypertension and,113
sudden cardiac death and dosages of for older adults,111
Trifluoperazine,2712 A’s+R (Ask, Advise, and Refer),249–250
U.S. Department of Health and Human Services,246
U.S. Preventive Services Task Force,149
U.S. Public Health Service,248, 250, 251
U.S. Surgeon General,93–94
University of California, Los Angeles,171
University of Southern California,171
Urinary system, diseases of,7, 13–14
Valproate,108,
271Valproic acid,118
Varenicline,253, 254, 256
Veterans Health Administration,132, 137, 273, 301
Virtual mental health care, and COVID-19 pandemic,292
Waist circumference, and metabolic syndrome,124
Walk, Address Sensations, Learn About Exercise, Cue Exercise Behavior for SSDs (WALC-S),176WebMOVE,186, 275,
276Weight gain and psychotropic medications,94, 105, 270.
See also Obesity
Wellness.
See also Health
challenges to health care utilization and,222,
223–
224impact of physical illness on,16–17
W.K. Kellogg Foundation,24
Women.
See also Gender
community-based participatory research and,30,
34depressive disorders and domestic violence,88
medical screening tests for,69
World Health Organization,16, 52
